HANLIM PHARMACEUTICAL CO., LTD.

City:

Gyeonggi-do

Country:

South Korea

Published Applications:

Last publication date:

2013-09-26

Patent Grants:

Last grant date:

2014-10-14

Top Inventors for applications by HANLIM PHARMACEUTICAL CO., LTD.

These are the the leading inventors for applications assigned to HANLIM PHARMACEUTICAL CO., LTD.:

Geun-Hyeog Lee 3 Gyeonggi-do, South Korea
Jin-Ha Park 3 Gyeonggi-do, South Korea
Byong-Sun Choi 2 Seoul, South Korea
Jun-Ki Min 2 Gyeonggi-do, South Korea

Yun Ju Woo 2 Seoul, South Korea
Hye Jwa Oh 2 Seoul, South Korea
Mi La Cho 2 Seoul, South Korea
Eun-Young Kwak 2 Seoul, South Korea

Se-Wan Park 1 Gyeonggi-do, South Korea
Sang-Yong Lee 1 Gyeonggi-do, South Korea
Jong-Hyeon Ryu 1 Gyeonggi-do, South Korea
Mi-Jin O. 1 Gyeonggi-do, South Korea

Young-Ok Jung 1 Seoul, South Korea
Joo-Yeon Jhun 1 Seoul, South Korea

Recent patent applications by HANLIM PHARMACEUTICAL CO., LTD.

HANLIM PHARMACEUTICAL CO., LTD. based in Gyeonggi-do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-09-26 ✅ Patent 8,859,531 granted on 2014-10-14

US20130252929A1

Human necessities

Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration

#2 | 2013-03-14 ✅ Patent 9,301,954 granted on 2016-04-05

US20130065920A1

Human necessities

Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient

#3 | 2012-07-05 ✅ Patent 8,691,842 granted on 2014-04-08

US20120172394A1

Human necessities

Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide

AssigneeID:

40564 ⎘